tirzepatide fda indications Ozempic, Wegovy, and Mounjaro: Prescribing trends tirzepatide fda indications The Landscape

[1] This cardiovascular effect is not unique to tirzepatide

In summary, Zepbound: Suppresses appetite and increases feelings of being full to decrease calorie consumption and lower food cravings Enhances insulin secretion, improves blood glucose control, and lowers hypoglycemia Delays gastric emptying so you feel fuller for longer and eat less Increases adiponectin levels to help regulate glucose levels and fatty acid breakdown As previously mentioned, Zepbound is injected weekly into the stomach, thigh, or upper arm

patients and clinicians should refer to the primary trial publication for specific figures, as these data are dose-dependent and subject to ongoing analysis

According to the Ozempic Summary of Product Characteristics, approved injection sites include the abdomen, thigh, or upper arm

doi: 10.1016/j.jri.2023.104128 195 FuseiniHCephusJ-YWuPDavisJBContrerasDCGandhiVDet al